Old Web
English
Sign In
Acemap
>
authorDetail
>
C. Abbrederis
C. Abbrederis
University of Innsbruck
Medicine
Immunology
Chronic myelogenous leukemia
Toxicity
Response rate (survey)
4
Papers
56
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Treatment of chronic myelogenous leukemia with interferon alfa-2c: response rate and toxicity in a phase II multicenter study. The Austrian Biological Response Modifier (BRM) Study Group.
1993
Seminars in Hematology
Josef Thaler
Gastl G
T. Fluckinger
Niederwieser D
H. Huber
H. L. Seewann
H. Silly
Alois Lang
C. Abbrederis
Helmut Gadner
Show All
Source
Cite
Save
Citations (13)
Treatment of chronic myelogenous leukemia with interferon alfa-2c : response rate and toxicity in a phase II multicenter study
1993
Seminars in Hematology
Josef Thaler
Gastl G
T. Fluckinger
Niederwieser D
H. Huber
H. L. Seewann
H. Silly
Alois Lang
C. Abbrederis
Helmut Gadner
W. Fereberger
L. Schiller
L. Kock
Michael A. Fridrik
Christoph Duba
M. Falk
M. Berger
Thomas Kühr
Christoph Huber
Show All
Source
Cite
Save
Citations (13)
Treatment of 11 patients with chronic myelogenous leukemia with interferon-alpha-2C and low-dose cytosine arabinoside.
1993
Leukemia Research
Josef Thaler
T. Fluckinger
H. Huber
Alois Lang
C. Abbrederis
H. L. Seewann
H. Silly
Christian Baldinger
Christoph Duba
Christoph Huber
Dietger Niederwieser
Show All
Source
Cite
Save
Citations (10)
Treatment with low dose human recombinant interferon-alpha-2-ARG induces complete remission in patients with hairy cell leukemia.
1985
Onkologie
Günther Gastl
H. Denz
C. Abbrederis
H. Huber
Jakob Troppmair
J. Wiegele
D. Niederwieser
R. Flener
Christoph Huber
Show All
Source
Cite
Save
Citations (20)
1